Augmented antibody-based anticancer therapeutics boost neutrophil cytotoxicityNiels Heemskerk, Marjolein van Egmond|Journal of Clinical Investigation|2021Cited by 59
Targeting the CD47-SIRPα Innate Immune Checkpoint to Potentiate Antibody Therapy in Cancer by NeutrophilsLeonie M. Behrens, Marjolein van Egmond|Cancers|2022Cited by 35
Antagonizing FcαR1 (CD89) as treatment in IgA-mediated chronic inflammation and autoimmunityMyrthe A. M. van Delft, Marjolein van Egmond|Frontiers in Immunology|2023Cited by 12
Fcα Receptor-1-Activated Monocytes Promote B Lymphocyte Migration and IgA Isotype SwitchingAmélie Bos, Marjolein van Egmond|International Journal of Molecular Sciences|2022Cited by 6